HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Dejka M Araujo Selected Research
Dejka M Araujo Research Topics
Disease
17
Neoplasms (Cancer)
05/2024 - 11/2011
10
Sarcoma (Soft Tissue Sarcoma)
05/2024 - 07/2009
9
Synovial Sarcoma (Synovioma)
03/2024 - 08/2014
5
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
04/2024 - 03/2008
4
Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 11/2011
3
Myxoid Liposarcoma
03/2024 - 01/2012
3
Leiomyosarcoma
01/2022 - 04/2013
3
Cardiotoxicity
01/2020 - 01/2010
3
Solitary Fibrous Tumors
05/2013 - 07/2010
2
Hemangiosarcoma (Angiosarcoma)
01/2022 - 07/2010
2
Extraskeletal Myxoid Chondrosarcoma
01/2020 - 11/2008
2
Heart Failure
06/2016 - 01/2010
2
Hemangiopericytoma
11/2011 - 07/2010
1
Chordoma
01/2022
1
Liposarcoma
01/2022
1
Colitis
01/2022
1
Alveolar Soft Part Sarcoma
01/2022
1
Pneumonia (Pneumonitis)
01/2022
1
Phyllodes Tumor (Cystosarcoma Phylloides)
04/2021
1
Chondrosarcoma
01/2020
1
Hypertension (High Blood Pressure)
01/2020
1
Genetic Translocation (Chromosomal Translocation)
12/2016
1
Cardiovascular Diseases (Cardiovascular Disease)
06/2016
1
Rhabdomyosarcoma
08/2014
1
Epithelioid Hemangioendothelioma
07/2010
1
Edema (Dropsy)
01/2010
1
Toxic Optic Neuropathy
03/2008
1
Keratitis
03/2008
1
Rheumatoid Arthritis
03/2008
1
Corneal Ulcer
03/2008
Drug/Important Bio-Agent (IBA)
4
Ifosfamide
FDA Link
Generic
03/2024 - 01/2012
3
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
03/2024 - 10/2019
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 06/2016
3
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2020 - 01/2012
3
Tyrosine Kinase Inhibitors
IBA
01/2020 - 07/2010
3
Imatinib Mesylate (Gleevec)
FDA Link
12/2018 - 03/2008
2
Immune Checkpoint Inhibitors
IBA
05/2024 - 10/2019
2
Anthracyclines
IBA
03/2024 - 06/2016
2
HLA-A Antigens (HLA-A)
IBA
03/2024 - 10/2019
2
pazopanib
FDA Link
01/2020 - 07/2010
2
Oncogene Proteins (Oncogene Protein)
IBA
11/2018 - 12/2016
2
Paraffin
IBA
11/2011 - 11/2008
2
Bevacizumab (Avastin)
FDA Link
11/2011 - 07/2010
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2011 - 07/2010
2
Formaldehyde (Formol)
FDA Link
11/2011 - 11/2008
1
Succinate Dehydrogenase (Fumarate Reductase)
IBA
04/2024
1
tremelimumab
IBA
01/2022
1
Cytokines
IBA
01/2022
1
durvalumab
IBA
01/2022
1
Lipase (Acid Lipase)
FDA Link
01/2022
1
Alanine Transaminase (SGPT)
IBA
01/2020
1
Trinitrotoluene (TNT)
IBA
01/2020
1
Transducin
IBA
01/2020
1
Troponin T (Troponin T1)
IBA
01/2020
1
Co-Repressor Proteins
IBA
01/2020
1
Dexrazoxane (Zinecard)
FDA Link
Generic
01/2020
1
Peptides (Polypeptides)
IBA
10/2019
1
Antigens
IBA
10/2019
1
Chromatin
IBA
11/2018
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
06/2016
1
Troponin I
IBA
06/2016
1
Insulin (Novolin)
FDA Link
08/2014
1
teprotumumab
IBA
08/2014
1
Monoclonal Antibodies
IBA
08/2014
1
Trabectedin
IBA
12/2012
1
Proteins (Proteins, Gene)
FDA Link
11/2011
1
Temozolomide (Temodar)
FDA Link
Generic
11/2011
1
Sorafenib (BAY 43-9006)
FDA Link
07/2010
1
Sunitinib (Sutent)
FDA Link
07/2010
1
Anti-Bacterial Agents (Antibiotics)
IBA
03/2008
1
perifosine
IBA
03/2008
1
Steroids
IBA
03/2008
Therapy/Procedure
18
Therapeutics
03/2024 - 07/2009
9
Drug Therapy (Chemotherapy)
03/2024 - 11/2011
3
Radiotherapy
05/2022 - 12/2012
1
Immunotherapy
10/2019
1
Drug Tapering
01/2010
1
Slit Lamp
03/2008
1
Activities of Daily Living (ADL)
03/2008